Evalve, Inc.

Evalve, Inc. designs, develops, manufactures, and markets devices that enable percutaneous repair of cardiac valves. It provides percutaneous mitral valve repair system that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.